Hyderabad-based Hetero gets DCGI nod to manufacture, market Molnupiravir capsules
New Delhi: Hyderabad-based pharmaceuticals firm Hetero Tuesday said it has received permission from the Drug Controller General of India (DCGI) ...
Read moreDetails
New Delhi: Hyderabad-based pharmaceuticals firm Hetero Tuesday said it has received permission from the Drug Controller General of India (DCGI) ...
Read moreDetailsHyderabad: Hetero, one of India's leading generic pharmaceutical companies and the world's largest producer of antiretroviral drugs, on Wednesday announced ...
Read moreDetailsNew Delhi: Four domestic pharma firms – Cipla, Jubilant Life Sciences, Hetero and Mylan – have entered into non-exclusive licensing agreements ...
Read moreDetails
News has come from Germany that might upset liberal and democratic forces across the world. The Far-Right Alternative for Germany...
Read moreDetails
Union Home Minister Amit Shah’s announcement on 13 September of the government’s resolve to enforce the Uniform Civil Code (UCC)...
Read moreDetails
What started with an apocalyptic warning from a former Anthropic researcher on 9 September that AI (Self improving super intelligence)...
Read moreDetails
By Aakar Patel "Attendance at the hearing is mandatory. Please treat this as urgent and make the necessary arrangements to...
Read moreDetails
